Surgery versus concurrent chemoradiotherapy for stage III non-small cell lung cancer: a retrospective study with propensity score matching
The outcomes of the surgery and cCRT groups did not significantly differ in the treatment of stage III NSCLC. Appropriate evaluation of the treatment required should be reviewed on a case-by-case basis.
Authors
- Tsuneo Shimokawa (ORCID: https://orcid.org/0000-0003-2219-5737)
- Takao Shigenobu
- Kazumasa Odagiri
- Takahiro Suzuki (ORCID: https://orcid.org/0000-0002-7949-5477)
- Yuri Taniguchi (ORCID: https://orcid.org/0000-0001-6409-1739)
- Yuya Tabuchi (ORCID: https://orcid.org/0000-0002-6056-871X)
- Akira Yoshizu
- Yukiko Nakamura (ORCID: https://orcid.org/0000-0002-0004-130X)
- Mizuki Sato (ORCID: https://orcid.org/0009-0000-0421-3554)
- Hiroaki Okamoto (ORCID: https://orcid.org/0000-0003-3110-5545)
Institutions
- Yokohama Municipal Citizen's Hospital (JP)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-01-22
- DOI
- https://doi.org/10.1186/s12885-025-13550-0
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00